NephroPharmacology


Meeting 2017

NephroPharmacology Meeting 2017
The 16th NephroPharmacology Meeting will be held in Heidelberg, Germany, October 21st.
 Program

10:00-10:10

Welcome and Introduction

Martin Zeier

Walter E. Haefeli

Claudia Sommerer

David Czock

(Heidelberg)

10:10-11:10

Main lecture  -   Chair: David Czock

 

Tackling the variability of immunosuppressive drugs: Clinical relevance of pharmacogenetics, drug-drug interactions, nonadherence, and the role of pharmacodynamic markers

 


Dirk Kuypers (Leuven)

11:10-11:30

Meet the expert with coffee and tea

 

 

 

Session I   -   Chair: Frieder Keller

 

 

11:30-11:50

Prospective immunomonitoring during the first year after kidney transplantation

 

Thomas Giese (Heidelberg)

11:50-12:10

Individualized calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: the Calcineurin Inhibitor-Sparing (CIS) trial

 

Claudia Sommerer (Heidelberg)

12:10-12:30

Assessment of reproducibility and inter-laboratory performance of the NFAT-regulated gene expression assay as a pharmacodynamic biomarker to monitor therapy with calcineurin inhibitors

 

Emaad Ahmed (Stuttgart)

12:30-12:50

The tacrolimus metabolism rate – ready for clinical routine?

 

Gerold Thölking (Münster)

12:50-13:40

Poster presentation with lunch

 

All

 

Session II   -   Chair: Claudia Sommerer

 

 

13:40-14:00

Phosphorylation of mTOR pathway molecules as specific biomarkers in organ transplantation

 

Markus Barten (Hamburg)

14:00-14:20

Impact of mTOR-inhibition on tolerance-induction following heart transplantation

 

Maja-T. Dieterlen (Leipzig)

14:20-14:40

Effects of ciclosporin and its combination with fluconazole on the pharmacokinetics of rivaroxaban in healthy volunteers

David Czock, Antonia Brings (Heidelberg)

14:40-15:00

Pharmacokinetics of daclatasvir, sofosbuvir and GS-331007 in a prospective cohort of HCV positive kidney transplant recipients

 

Eva-Vanessa Schrezenmeier (Berlin)

15:00-15:20

Fosfomycin dosing during extended dialysis in critically ill patients – case presentations and dosing considerations

Julius Schmidt (Hannover)

15:20-15:40

Poster presentation with coffee and tea

 

All

 

Session III   - Chair: David Czock

 

 

15:40-16:00

Systematic review of case reports on pharmacokinetic assessments in individual patients on chronic hemodialysis

Verena Gotta (Basel)

16:00-16:20

Augmented renal clearance – an important aspect of renal function

Anders Hellden (Linköping)

16:20-16:40

Does eGFR individualization by body surface area influence dose recommendations for oral antidiabetic drugs? – Sitagliptin and metformin as an example

Sarah Seiberth (München)

16:40-17:00

Effect bisection time and administration interval of PCSK9-inhibitors

 

Frieder Keller (Ulm)

17:00

Wrap up and Perspectives

Closure of the Meeting

Frieder Keller

David Czock

Claudia Sommerer